Kopran Ltd. — Investor Relations & Filings

Kopran Ltd. is an integrated organization specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms. The company maintains a significant focus on semi-synthetic penicillins and cephalosporins, alongside a diverse portfolio covering therapeutic areas such as cardiovascular health, diabetes management, and anti-infectives. Operating through advanced manufacturing facilities that adhere to international quality benchmarks, the entity provides a vertically integrated supply chain. Its core activities encompass chemical synthesis and the production of oral solids and dry powder injectables. With a dedicated emphasis on research and development, the company serves a global clientele, focusing on high-quality medicinal solutions and process optimization.